1413TiP LIBRETTO-431: Selpercatinib in treatment (Tx)-naïve patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC)

Authors :: Yasir Elamin
Geoffrey R. Oxnard
Victoria Soldatenkova
Juergen Wolf
Andreas Sashegyi
C. Zhou
Herbert H. Loong
A. Drilon
Fernando C. Santini
K. Park
Boris Lin
Ben Solomon
Koichi Goto
A. Bence Lin
Source :: Annals of Oncology. 31:S893
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Therapy naive
Oncology
business.industry
RET Fusion Positive
medicine
Cancer research
non-small cell lung cancer (NSCLC)
Hematology
medicine.disease
business

Full Text Access

Tools